5 of the Most Hated Biotech Stocks on the Market: Are They Buys?
One of the best ways to measure how much a stock is hated is by looking at the percentage of the stock's float that's sold short. Short-sellers think so poorly of a stock that they're willing to put money on the line that its price will fall.
Five biotech stocks appear to have incurred a lot of hate based on their levels of short interest: Agios Pharmaceuticals (NASDAQ: AGIO), Insys Therapeutics (NASDAQ: INSY), Intercept Pharmaceuticals (NASDAQ: ICPT), Lexicon Pharmaceuticals (NASDAQ: LXRX), and Myriad Genetics (NASDAQ: MYGN). But are these hated stocks actually smart picks to buy right now?
Image source: Getty Images.
Source: Fool.com
Lexicon Pharmaceuticals Inc. Stock
€2.20
-2.230%
Currently there is a rather positive sentiment for Lexicon Pharmaceuticals Inc. with 5 Buy predictions and 0 Sell predictions.
Based on the current price of 2.2 € the target price of 9 € shows a potential of 309.46% for Lexicon Pharmaceuticals Inc. which would more than double the current price.
